Novartis can’t appeal loss of experts in MS drug patent feud with Pharmacor

Intellectual Property 2022-04-07 12:29 pm By Christine Caulfield | Melbourne

The Full Federal Court won’t give Swiss pharmaceuticals giant Novartis the chance to appeal a ruling that threw out three of its four experts in a patent case against generic drug maker Pharmacor.